Financials

News Discussions Technicals Seasonals

LYTIX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Lytix Biopharma AS engages in the development of novel drugs for the treatment of resistant bacterial and fungal infections, as well as oncology treatments. The company was founded by Øystein Rekdal and John Sigurd Mjøen Svendsen in 2003 and is headquartered in Tromso, Norway.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

LYTIX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company